The Schall Law Firm Investigates Cardlytics, Inc. for Potential Securities Law Violations
Los Angeles, CA – The Schall Law Firm, a leading national shareholder rights litigation firm, announces that it is investigating potential securities laws violations by Cardlytics, Inc. (“Cardlytics” or “the Company”) (NASDAQ: CDLX). This investigation follows a lawsuit filed on behalf of investors who purchased or held Cardlytics securities between February 25, 2021, and October 26, 2021, inclusive (the “Class Period”).
Allegations of False and Misleading Statements
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Specifically, the complaint alleges that Cardlytics made false and/or misleading statements and/or failed to disclose that:
- The Company’s financial results for the second quarter of 2021 would be negatively impacted by the termination of its agreement with a major customer;
- Cardlytics’ financial results for the third quarter of 2021 would also be negatively impacted by the termination of this agreement;
- The Company had not disclosed the material impact of the termination of this agreement on its revenue and financial results.
Impact on Individual Investors
If the allegations in the complaint are true, investors who purchased or held Cardlytics securities during the Class Period may be able to recover their losses through the securities class action. The Schall Law Firm encourages investors who are affected by this situation to contact the firm before the February 28, 2026, lead plaintiff deadline.
Impact on the World
The investigation into Cardlytics’ potential securities law violations could have significant implications for the financial industry as a whole. If the allegations are proven true, it could send a strong message to publicly traded companies to be more transparent with their investors about any potential negative impacts on their financial results. Furthermore, it could lead to increased scrutiny of the financial reporting practices of other companies in the industry.
Conclusion
The Schall Law Firm is committed to securing justice for investors who have been harmed by corporate wrongdoing. If you purchased or held Cardlytics securities during the Class Period and believe you may be a victim of securities fraud, we encourage you to contact us before the lead plaintiff deadline. Our team of experienced attorneys will provide you with a free, no-obligation consultation, and we will help you understand your legal rights and options.
The investigation into Cardlytics’ potential securities law violations is ongoing, and we will continue to provide updates as more information becomes available. If you have any questions or concerns, please do not hesitate to contact us.
